Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Cell Suspension Grafting Using ReNovaCell in Non-segmental Vitiligo Patients: a Randomized Controlled Study

NCT03022019 is registered in ClinicalTrials.gov with Netherlands Institute for Pigment Disorders as lead sponsor.

NCT NCT03022019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03022019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Cell Suspension Grafting Using ReNovaCell in Non-segmental Vitiligo Patients: a Randomized Controlled Study
Lead sponsor
Netherlands Institute for Pigment Disorders
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2016
Completion date
May 14, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-segmental vitiligo, vitiligo